Cerity Partners’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGN
PCM
AA
Cerity Partners's OGN Position: Q2 2026 in Review
Cerity Partners reduced its Organon & Co (OGN) stake by 56% in Q2 2026, selling an estimated $15.5M and leaving 1,009,842 shares worth $13.7M. The position accounts for 0.02% of the portfolio, ranked #617.
Cerity Partners first reported a position in OGN in Q2 2022 and has held it in 14 quarters since. The position peaked at $17.7M in Q3 2025. 633 funds tracked by Wall St. Rank hold OGN as of Q2 2026.
- Cerity Partners held 1,009,842 shares of Organon & Co worth $13.7M as of Q2 2026.
- Cerity Partners sold 1,299,197 Organon & Co shares in Q2 2026, an estimated $15.5M.
- Organon & Co made up 0.02% of Cerity Partners's portfolio in Q2 2026, its #617 holding.
- Cerity Partners first reported a position in Organon & Co in Q2 2022 and has held it in 14 quarters since.
- Cerity Partners's Organon & Co position peaked at $17.7M in Q3 2025.
- 633 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.
Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.